Cargando…

Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study

BACKGROUND: We sought to determine the comparative efficacy of fosfomycin vs ertapenem for outpatient treatment of complicated urinary tract infections (cUTIs). METHODS: We conducted a multicenter, retrospective cohort study involving patients with cUTI treated with outpatient oral fosfomycin vs int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wald-Dickler, Noah, Lee, Todd C, Tangpraphaphorn, Soodtida, Butler-Wu, Susan M, Wang, Nina, Degener, Tyler, Kan, Carolyn, Phillips, Matthew C, Cho, Edward, Canamar, Catherine, Holtom, Paul, Spellberg, Brad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754378/ https://www.ncbi.nlm.nih.gov/pubmed/35036466 http://dx.doi.org/10.1093/ofid/ofab620

Ejemplares similares

Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen
por: Banerjee, Josh, et al.
Publicado: (2021)

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae
por: Gubenšek, Urša, et al.
Publicado: (2022)

Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
por: Phillips, Matthew C, et al.
Publicado: (2020)

SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases
por: Phillips, Matthew C., et al.
Publicado: (2022)

A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay
por: Khoshchehreh, Mahdi, et al.
Publicado: (2020)

Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration
por: Britt, Rachel S, et al.
Publicado: (2019)

Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting
por: Derington, Catherine G, et al.
Publicado: (2020)

Under-allocation: Critical Supply Chain Hurdles Negatively Impact the Ability of Community Hospitals To Perform Repeat SARS-CoV-2 Testing
por: Butler-Wu, Susan M., et al.
Publicado: (2020)

Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort Study
por: Adelman, Max W, et al.
Publicado: (2021)

Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis
por: Gilbertie, Jessica, et al.
Publicado: (2022)

Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin
por: Grant, Rebecca, et al.
Publicado: (2023)

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost
por: Kalatharan, L, et al.
Publicado: (2023)

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
por: Pericàs, Juan M, et al.
Publicado: (2022)

From prostate to the pons: The first reported case of multi‐organ septic emboli and brain empyema from an untreated prostate abscess
por: Degener, Tyler, et al.
Publicado: (2021)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

Evaluating the Impact of Long-Term Outpatient Ertapenem (ETP) vs. Ceftriaxone (CTX) on Clinical Success and Development of Resistance for Documented Enterobacteriaceae Infections
por: Carver, Peggy, et al.
Publicado: (2017)

Ertapenem-Induced Thrombocytosis
por: Docobo, Ramon A, et al.
Publicado: (2017)

602. Clinical Outcomes of Ertapenem in Patients with Hypoalbuminemia
por: Gavaghan, Victoria, et al.
Publicado: (2022)

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
por: Ortiz-Álvarez, Arturo, et al.
Publicado: (2018)

Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments
por: Bookstaver, P Brandon, et al.
Publicado: (2018)

1102. Ertapenem vs. Nonertapenem Antibiotics in Colorectal Surgery: A Stewardship Opportunity
por: LaDow, Tiffany, et al.
Publicado: (2019)

The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
por: Reiersen, Angela M, et al.
Publicado: (2023)

Evaluation of the FilmArray Meningitis/Encephalitis Molecular Panel in a Tertiary Care Public County Hospital
por: Kim, Tae Hun, et al.
Publicado: (2017)

A More Accurate Measurement of the Burden of Coronavirus Disease 2019 Hospitalizations
por: Vu, Christina, et al.
Publicado: (2022)

Ertapenem Resistance of Escherichia coli
por: Lartigue, Marie-Frédérique, et al.
Publicado: (2007)

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
por: Pujol, Miquel, et al.
Publicado: (2020)

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020)

Outpatient Therapies for COVID-19: How Do We Choose?
por: Lee, Todd C, et al.
Publicado: (2022)

Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study
por: Fink, Doug L., et al.
Publicado: (2019)

2362. SARS-CoV-2 Omicron Variants Associated with Less Severe Disease in Hospitalized Patients Irrespective of Baseline Risk Factors and Immunity
por: Lee, Austin, et al.
Publicado: (2023)

Invasive Obstetric Procedures and Cesarean Sections in Women With Known Herpes Simplex Virus Status During Pregnancy
por: Stankiewicz Karita, Helen C, et al.
Publicado: (2017)

The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study
por: Blair, Paul W, et al.
Publicado: (2021)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Outpatient Antibiotic Prescribing in Massachusetts, 2011–2015
por: Klevens, R Monina, et al.
Publicado: (2019)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Self-Collected Oral Fluid Saliva Is Insensitive Compared With Nasal-Oropharyngeal Swabs in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Outpatients
por: Manabe, Yukari C, et al.
Publicado: (2020)

Ertapenem for treatment of osteomyelitis: a case series
por: Goswami, Neela D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_glr3j76e9fmkec9nv7h4hc70b0